Impact BioMedical Inc.
corporate_fare Company Profile
Impact BioMedical Inc. (NYSE:IBO) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 3 items for IBO at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-11-18, rated 9/10. Across its 3 most recent items scored 7 or higher, the top rating is 9/10, with 3 rated 8 or above. Recent SEC coverage for IBO spans 8-K, 10-Q.
Recent high-impact activity:
- Impact BioMedical Closes Zoar Merger; IBO Delisted, PubCo Trades as ZOAR
- Impact BioMedical Shareholders Approve Zoar Merger With 99.97% of Votes Cast
- Impact BioMedical 10-Q: Going Concern Warning With Just $21,000 Cash on Hand
Financial Snapshot
Short Interest & Short Volume
1.15 days to coverFINRA reported short interest of 24,619 shares in IBO as of the October 30, 2026 settlement, a 6.4% decrease from the prior period — about 1.1 days to cover at its recent average daily volume. On November 17, 2026, 42.4% of IBO volume reported to FINRA trade-reporting facilities was marked short.
Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.